Search All News
The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
- May 21, 2021
A trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate seen in the control arm (12.6% vs. 24.6%).
- May 19, 2021
Though many COVID-19 patients fully recover, some people develop such a degree of scarring in their lungs that they need a transplant.
- May 18, 2021
The post-COVID Community Mental Health Project aims to promote wellness and increase access to behavioral health services in underserved New York City neighborhoods.
- May 4, 2021
Hundreds of New Yorkers from Harlem, Northern Manhattan, and Morningside Heights have been vaccinated at Columbia's Community Pop-up Vaccination Site.
- April 29, 2021
A new study is drawing the most detailed picture yet of SARS-CoV-2 infection in the lung revealing mechanisms that cause lethal COVID-19 and how COVID-19 differs from other infectious diseases.
- April 16, 2021
A virtual town hall on COVID-19 vaccines welcomed community health workers and keynote speaker Judith Absalon, MD, MPH.
- April 9, 2021
After implementing an array of extra safety measures, routine dental care is rebounding at Columbia’s College of Dental Medicine.
- April 6, 2021
Mailman's ICAP program is well-known for its efforts in fighting HIV, malaria, and TB around the world, but they're also busy in the fight against COVID-19 in nearby Harlem and Bronx neighborhoods.